GeoVax Labs, Inc.
1900 Lake Park Drive
Suite 380
Smyrna, Georgia 30080
(678) 384-7220
June 22, 2022
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Re: | GeoVax Labs, Inc. |
| Registration Statement on Form S-1 |
| File No. 333-265583 |
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-265583) filed with the U.S. Securities and Exchange Commission on June 14, 2022, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Friday, June 24, 2022 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act.
If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.
Very truly yours, | |||
GeoVax Labs, Inc. | |||
By: | /s/ Mark W. Reynolds | ||
Mark W. Reynolds | |||
Chief Financial Officer |